ILSI-Biomed Israel

The 2009 Best Biomed Competition is Starting

The Life Science Accelerator (LSA)  is announcing the 2009 competition for Best Biomed Initiative, with a $ 47,450 worth first prize How would you like to give your start-up a major startup? The Life Science Accelerator (LSA) is giving Israelian biomed companies that kind of a chance, by opening the Best Biomed Initiative. The best company will win up to $ 47,450 worth (combined) of professional service package by the leading service providers, including full patent application draft serv...

Neurologists Investigate a Possible New Underlying Cause of Multiple Sclerosis

A new study sets out to determine whether multiple sclerosis is actually the result of a narrowing of veins outside the skull Common knowledge holds that multiple sclerosis (MS) is the result of an abnormal immune response against the patient’s nervous system. However, common knowledge might go awry. As it turns out, MS is also strongly associated with a narrowing of the primary veins outside the skull, a condition called “chronic cerebrospinal venous insufficiency”. The narrowin...

Welcome to ILSI-Biomed Israel blog!

A place for all things bio and med, where Israel’s vibrant life science community comes together. Connect with old and new friends, explore business relationships and learn about the future and present of healthcare and biotechnology, in Israel and in the world. The ILSI-Biomed webpage will focus on: Information about new biomed technologies Connecting innovators, executives, entrepreneurs, researchers, policy makers and industry investors in the field of biopharma Shedding light...